Ribavirin Concentrations Do Not Predict Sustained Virological Response in HIV/HCV-Coinfected Patients Treated with Ribavirin and Pegylated Interferon in the Swiss HIV Cohort Study

BACKGROUND: Ribavirin (RBV) is an essential component of most current hepatitis C (HCV) treatment regimens and still standard of care in the combination with pegylated interferon (pegIFN) to treat chronic HCV in resource limited settings. Study results in HIV/HCV-coinfected patients are contradictin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS One
Main Authors: Kovari, Helen, Russmann, Stefan, Ledergerber, Bruno, Müller, Daniel, Rotger, Margalida, Velli, Pablo, Cavassini, Matthias, Ambrosioni, Juan, Bregenzer, Andrea, Stöckle, Marcel, Bernasconi, Enos, Rauch, Andri, Speck, Roberto F.
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2015
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4517877/
https://ncbi.nlm.nih.gov/pubmed/26218843
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0133879
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados